Current Problems in Cancer
Volume 34, Issue 1 , Pages 65-76 , January 2010

Imaging of Merkel Cell Carcinoma

References 

  1. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. Merkel cell carcinoma. J Natl Compr Canc Netw. 2009;7:322–332
  2. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4:389–395
  3. Ortin-Perez J, van Rijk MC, Valdes-Olmos RA, Vidal-Sicart S, Nieweg OE, Vilalta A, et al. Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol. 2007;33:119–122
  4. Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krössin T, et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006;33:433–440
  5. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008;15:2509–2518
  6. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma (The Dana-Farber experience and meta-analysis of the literature). Arch Dermatol. 2006;142:685–690
  7. Stadelmann WK, Cobbins L, Lentsch EJ. Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients. Ann Plast Surg. 2004;52:546–549discussion 550
  8. Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck. 2007;29:979–985
  9. Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck. 2000;22:27–33
  10. Doting EH, De Vries M, Plukker JT, Jager PL, Post WJ, Suurmeijer AJ, et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome?. J Surg Oncol. 2006;93:564–570
  11. Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res. 2009;19:94–99
  12. Mar MV, Miller SA, Kim EE, Macapinlac HA. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol. 2007;35:10–16
  13. Voit C, Kron M, Schäfer G, Schoengen A, Audring H, Lukowsky A, et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol. 2006;13:1682–1689
  14. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer. 2000;88:2534–2539
  15. Davis JT, Brill YM, Simmons S, Sachleben BC, Cibull ML, McGrath P, et al. Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis. Ann Surg Oncol. 2006;13:1545–1552
  16. Eggermont AM. Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodes. Ann Surg Oncol. 2005;12:3–5
  17. van Rijk MC, Teertstra HJ, Peterse JL, Nieweg OE, Olmos RA, Hoefnagel CA, et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol. 2006;13:1511–1516
  18. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol. 2005;12:18–23
  19. Rossi CR, Pasquali S, Mocellin S. Actual false-negative rate prompts the routine use of ultrasound scan before and after sentinel node biopsy in melanoma. Ann Surg Oncol. 2008;15:2976–2977
  20. Gollub MJ, Gruen DR, Dershaw DD. Merkel cell carcinoma: CT findings in 12 patients. AJR Am J Roentgenol. 1996;167:617–620
  21. Yamamoto Y, Kameyama R, Murota M, Bandoh S, Ishii T, Nishiyama Y. Early assessment of therapeutic response using FDG PET in small cell lung cancer. Mol Imaging Biol. 2009;11:467–472
  22. Belhocine T, Pierard GE, Frühling J, Letesson G, Bolle S, Hustinx R, et al. Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep. 2006;16:347–352
  23. Golan H, Volkov O, Linchinsky O, Melloul M. FDG-PET imaging in Merkel cell carcinoma—value of head-to-toe scan. Nucl Med Rev Cent East Eur. 2005;8:135–136
  24. Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86–90
  25. Iagaru A, Quon A, McDougall IR, Gambhir SS. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18]fluoro-d-glucose-positron emission tomography/computed tomography?. Mol Imaging Biol. 2006;8:212–217
  26. Yao M, Smith RB, Hoffman HT, Funk GF, Graham MM, Buatti JM. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol. 2005;28:205–210
  27. Peloschek P, Novotny C, Mueller-Mang C, Weber M, Sailer J, Dawid M, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol. 2010;73:317–323
  28. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol. 2007;57:166–169
  29. Watanabe N, Shimizu M, Kageyama M, Kitagawa K, Hayasaka S, Seto H. 123I-MIBG SPECT of Merkel cell carcinoma. Br J Radiol. 1998;71:886–887
  30. Kwekkeboom DJ, Hoff AM, Lamberts SW, Oei HY, Krenning EP. Somatostatin analogue scintigraphy (A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases). Arch Dermatol. 1992;128:818–821
  31. Guitera-Rovel P, Lumbroso J, Gautier-Gougis MS, Spatz A, Mercier S, Margulis A, et al. Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. Ann Oncol. 2001;12:807–811
  32. Durani BK, Klein A, Henze M, Haberkorn U, Hartschuh W. Somatostatin analogue scintigraphy in Merkel cell tumours. Br J Dermatol. 2003;148:1135–1140
  33. Ikawa F, Kiya K, Uozumi T, Yuki K, Takeshita S, Hamasaki O, et al. Brain metastasis from Merkel cell carcinoma: case report and review of the literature. Neurosurg Rev. 1999;22:54–57
  34. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8:204–208
  35. Cheuk W, Kwan MY, Suster S, Chan JK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med. 2001;125:228–231
  36. Practice guidelines in oncology. Version 1 2008. Ft Washington, PA: National Comprehensive Cancer Network, Inc; 2008;

PII: S0147-0272(10)00015-2

doi: 10.1016/j.currproblcancer.2010.01.003

Current Problems in Cancer
Volume 34, Issue 1 , Pages 65-76 , January 2010

Article Tools

* Image Usage & Resolution